Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-04-24

Clinical Trial Update: Lamotrigine and Oral Contraceptives [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating lamotrigine in combination with oral contraceptives for epilepsy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

Sponsor: University of Aarhus | Conditions: Epilepsy | Phase 3 | Status: TERMINATED